BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2010
View Archived Issues
HSP 90 inhibitors show potent activity in preclinical models of CRPC
Read More
Merck & Co. identifies new gamma-secretase modulators
Read More
New PI3K-gamma inhibitors disclosed by Cellzome
Read More
ArQule's ARQ-197 shows promise in phase I/II trials in solid tumors
Read More
GlaxoSmithKline claims new orexin receptor antagonists
Read More
Belgian scientists claim new inhibitors of Flaviviridae replication
Read More
CVX-060 MAb evaluated in solid tumors in first-in-human trial
Read More
SF-353 exhibits antidepressant effects in preclinical tests
Read More
Open-label, extension-phase data support long-term use of rotigotine in RLS
Read More
Preclinical data support clinical evaluation of apadenoson in sickle cell anemia
Read More
Clinical trial of LTX-315/GV-1001 cancer therapy set to begin
Read More
Salix submits NDA to FDA for Xifaxan
Read More
Osta Biotechnologies discloses preclinical data on OB-28 in melanoma
Read More
FDA grants marketing clearance for Xpert SA Nasal Complete
Read More
Interim phase IIb data show safety and tolerability of RG-7128 in hepatitis C
Read More
FDA delays phase II trial of CH-4051 in rheumatoid arthritis
Read More
Rilonacept meets primary endpoint in Regeneron's phase III trial in gout
Read More
UCB and Wilex strengthen strategic alliance for oncology projects
Read More
HGS reports phase II data on mapatumumab in advanced multiple myeloma
Read More
CoLucid presents trial data showing efficacy of oral lasmiditan
Read More
Safety trial of ARV vaginal ring to prevent HIV infection starts in Africa
Read More
Revotar begins phase II trial of inhaled bimosiamose in COPD
Read More
S*BIO completes enrollment in phase II SB-1518 trials in myelofibrosis
Read More
Astellas acquires OSI Pharmaceuticals
Read More
FDA advisory committee recommends approval of fingolimod for relapsing MS
Read More
Blood estradiol identified as putative biomarker for testicular mature teratoma
Read More